African histoplasmosis: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = African histoplasmosis | |||
| synonyms = [[Histoplasmosis capsulati africana]] | |||
| field = [[Infectious disease]] | |||
| symptoms = [[Skin lesions]], [[lymphadenopathy]], [[fever]], [[cough]], [[weight loss]] | |||
| complications = [[Chronic pulmonary disease]], [[disseminated disease]] | |||
| onset = Variable | |||
| duration = Chronic | |||
| causes = [[Fungal infection]] by ''[[Histoplasma capsulatum var. duboisii]]'' | |||
| risks = [[Immunocompromised state]], [[HIV/AIDS]], [[exposure to bird or bat droppings]] | |||
| diagnosis = [[Culture (microbiology)|Culture]], [[histopathology]], [[serology]] | |||
| differential = [[Tuberculosis]], [[leprosy]], [[sarcoidosis]], [[cutaneous leishmaniasis]] | |||
| prevention = Avoidance of exposure to contaminated environments | |||
| treatment = [[Antifungal medication]] such as [[itraconazole]], [[amphotericin B]] | |||
| prognosis = Variable, depends on immune status and treatment | |||
| frequency = Endemic in [[Sub-Saharan Africa]] | |||
}} | |||
'''African Histoplasmosis''' is a fungal infection caused by ''[[Histoplasma capsulatum]] var. duboisii'', a variant of the fungus ''Histoplasma capsulatum'' which is endemic to certain parts of Africa. Unlike the more common form of histoplasmosis found in the Americas, which primarily affects the lungs, African histoplasmosis often involves the skin, bones, and other organs. | '''African Histoplasmosis''' is a fungal infection caused by ''[[Histoplasma capsulatum]] var. duboisii'', a variant of the fungus ''Histoplasma capsulatum'' which is endemic to certain parts of Africa. Unlike the more common form of histoplasmosis found in the Americas, which primarily affects the lungs, African histoplasmosis often involves the skin, bones, and other organs. | ||
==Etiology== | ==Etiology== | ||
African histoplasmosis is caused by the fungal organism ''Histoplasma capsulatum'' var. duboisii. The fungus thrives in soil enriched with bat or bird droppings. Infection occurs when spores are inhaled, although direct inoculation through the skin has been reported. | African histoplasmosis is caused by the fungal organism ''Histoplasma capsulatum'' var. duboisii. The fungus thrives in soil enriched with bat or bird droppings. Infection occurs when spores are inhaled, although direct inoculation through the skin has been reported. | ||
==Epidemiology== | ==Epidemiology== | ||
This disease is predominantly found in Central and West Africa, with cases reported in countries such as Nigeria, Democratic Republic of Congo, and Ghana. It affects individuals of all ages but has a higher incidence in males and rural populations, likely due to increased exposure to the endemic areas. | This disease is predominantly found in Central and West Africa, with cases reported in countries such as Nigeria, Democratic Republic of Congo, and Ghana. It affects individuals of all ages but has a higher incidence in males and rural populations, likely due to increased exposure to the endemic areas. | ||
==Clinical Manifestations== | ==Clinical Manifestations== | ||
The clinical presentation of African histoplasmosis can vary significantly. It often presents with chronic skin lesions that may ulcerate. Lymphadenopathy, osteolytic bone lesions, and respiratory symptoms may also occur. Disseminated disease is not uncommon and can affect the liver, spleen, and central nervous system. | The clinical presentation of African histoplasmosis can vary significantly. It often presents with chronic skin lesions that may ulcerate. Lymphadenopathy, osteolytic bone lesions, and respiratory symptoms may also occur. Disseminated disease is not uncommon and can affect the liver, spleen, and central nervous system. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of African histoplasmosis is challenging and relies on a combination of clinical suspicion, epidemiological context, histopathological examination, and culture of the fungus from clinical specimens. Serological tests and molecular methods such as PCR can also aid in diagnosis but may not be readily available in endemic regions. | Diagnosis of African histoplasmosis is challenging and relies on a combination of clinical suspicion, epidemiological context, histopathological examination, and culture of the fungus from clinical specimens. Serological tests and molecular methods such as PCR can also aid in diagnosis but may not be readily available in endemic regions. | ||
==Treatment== | ==Treatment== | ||
The treatment of choice for African histoplasmosis is the antifungal medication itraconazole, with amphotericin B used in severe or disseminated cases. The duration of treatment varies depending on the severity and site of infection but typically lasts for several months. | The treatment of choice for African histoplasmosis is the antifungal medication itraconazole, with amphotericin B used in severe or disseminated cases. The duration of treatment varies depending on the severity and site of infection but typically lasts for several months. | ||
==Prevention== | ==Prevention== | ||
Preventive measures are limited but include reducing exposure to endemic areas, especially avoiding activities that disturb soil in these regions. There is currently no vaccine available for histoplasmosis. | Preventive measures are limited but include reducing exposure to endemic areas, especially avoiding activities that disturb soil in these regions. There is currently no vaccine available for histoplasmosis. | ||
==Prognosis== | ==Prognosis== | ||
With appropriate antifungal therapy, the prognosis for localized African histoplasmosis is generally good. However, disseminated disease can be fatal, especially in immunocompromised individuals, highlighting the importance of early diagnosis and treatment. | With appropriate antifungal therapy, the prognosis for localized African histoplasmosis is generally good. However, disseminated disease can be fatal, especially in immunocompromised individuals, highlighting the importance of early diagnosis and treatment. | ||
==See Also== | ==See Also== | ||
* [[Histoplasmosis]] | * [[Histoplasmosis]] | ||
* [[Fungal infection]] | * [[Fungal infection]] | ||
* [[Mycosis]] | * [[Mycosis]] | ||
[[Category:Infectious diseases]] | [[Category:Infectious diseases]] | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] | ||
[[Category:Diseases and disorders in Africa]] | [[Category:Diseases and disorders in Africa]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 22:22, 3 April 2025
| African histoplasmosis | |
|---|---|
| Synonyms | Histoplasmosis capsulati africana |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin lesions, lymphadenopathy, fever, cough, weight loss |
| Complications | Chronic pulmonary disease, disseminated disease |
| Onset | Variable |
| Duration | Chronic |
| Types | N/A |
| Causes | Fungal infection by Histoplasma capsulatum var. duboisii |
| Risks | Immunocompromised state, HIV/AIDS, exposure to bird or bat droppings |
| Diagnosis | Culture, histopathology, serology |
| Differential diagnosis | Tuberculosis, leprosy, sarcoidosis, cutaneous leishmaniasis |
| Prevention | Avoidance of exposure to contaminated environments |
| Treatment | Antifungal medication such as itraconazole, amphotericin B |
| Medication | N/A |
| Prognosis | Variable, depends on immune status and treatment |
| Frequency | Endemic in Sub-Saharan Africa |
| Deaths | N/A |
African Histoplasmosis is a fungal infection caused by Histoplasma capsulatum var. duboisii, a variant of the fungus Histoplasma capsulatum which is endemic to certain parts of Africa. Unlike the more common form of histoplasmosis found in the Americas, which primarily affects the lungs, African histoplasmosis often involves the skin, bones, and other organs.
Etiology[edit]
African histoplasmosis is caused by the fungal organism Histoplasma capsulatum var. duboisii. The fungus thrives in soil enriched with bat or bird droppings. Infection occurs when spores are inhaled, although direct inoculation through the skin has been reported.
Epidemiology[edit]
This disease is predominantly found in Central and West Africa, with cases reported in countries such as Nigeria, Democratic Republic of Congo, and Ghana. It affects individuals of all ages but has a higher incidence in males and rural populations, likely due to increased exposure to the endemic areas.
Clinical Manifestations[edit]
The clinical presentation of African histoplasmosis can vary significantly. It often presents with chronic skin lesions that may ulcerate. Lymphadenopathy, osteolytic bone lesions, and respiratory symptoms may also occur. Disseminated disease is not uncommon and can affect the liver, spleen, and central nervous system.
Diagnosis[edit]
Diagnosis of African histoplasmosis is challenging and relies on a combination of clinical suspicion, epidemiological context, histopathological examination, and culture of the fungus from clinical specimens. Serological tests and molecular methods such as PCR can also aid in diagnosis but may not be readily available in endemic regions.
Treatment[edit]
The treatment of choice for African histoplasmosis is the antifungal medication itraconazole, with amphotericin B used in severe or disseminated cases. The duration of treatment varies depending on the severity and site of infection but typically lasts for several months.
Prevention[edit]
Preventive measures are limited but include reducing exposure to endemic areas, especially avoiding activities that disturb soil in these regions. There is currently no vaccine available for histoplasmosis.
Prognosis[edit]
With appropriate antifungal therapy, the prognosis for localized African histoplasmosis is generally good. However, disseminated disease can be fatal, especially in immunocompromised individuals, highlighting the importance of early diagnosis and treatment.
